Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MarketWatch

Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug

Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
ShareXFacebook

Eli Lilly shares jumped in premarket trade on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.

M

Source

MarketWatch

Read full article at MarketWatch

Opens original article in a new tab

Advertisement

Related Economy Stories

Advertisement